VC  Bio-Star Ventures

https://www.biostarventures.com





     Office Locations:

560 W. Mitchell Street, Suite 500
Petoskey, MI 49770
Phone: 231-487-9186
Fax: 231-487-9183

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    BioStar Ventures is a venture capital partnership formed in 2003 by physicians and medical business leaders to invest primarily in early-stage medical devices. BioStar prefers to invest in the cardiovascular, orthopedic, neuroscience, and gastroenterology clinical specialties, but the partners are also interested in looking at biomaterials and how they can be used in any type of clinical area. If appropriate, BioStar will serve as lead investor but will participate in follow on investments as well. The firm's initial investment in a company ranges from $250K - $3 million, depending on the technology and stage of a company's development. BioStar intends to support portfolio companies in their follow-on financing rounds through time of exit. Accordingly, BioStar invests between $2 - $6 million over the life of an investment. BioStar invests in companies throughout the United States and has offices in Michigan, Philadelphia, and California.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    David J. Brophy PhD Director
    Jim Bennethum Director
    Louis A. Cannon MD Founder and Senior Managing Director
    Paul A. Scott Chief Financial Officer and Managing Director
    Renee Masi Managing Director

     

    Portfolio companies include:


      Ablative Solutions
        web link


      Angioslide Ltd.
        web link


      AorTX
        web link


      Aria CV, Inc.
        web link


      Atritech
        web link


      Autonomix Medical, Inc.
        web link


      Avantis Medical Systems
        web link


      Axis Surgical Technologies


      Bioabsorbable Therapeutics
        web link


      Broncus Technologies
        web link


      CardiacMD
        web link


      Conventus Orthopaedics, Inc.
        web link


      Corindus Vascular Robotics, Inc.
        web link


      CV Ingenuity
        web link


      Devax
        web link


      Domain Surgical
        web link


      Ellipse Technologies
        web link


      Embrella Cardiovascular
        web link


      Guided Delivery Systems
        web link


      Hotspur Technologies
        web link


      Interventional Spine
        web link


      Kona Medical
        web link


      MiCardia
        web link


      NanoMed Systems
        web link


      Nellix Endovascular
        web link


      NewPace Ltd.
        web link


      OmniGuide, Inc.
        web link


      Onset Medical
        web link


      Ortho-Space
        web link


      Phoenix Biomedical
        web link


      Revascular Therapeutics
        web link


      Reverse Medical


      Setagon
        web link


      SynergEyes
        web link


      TransMedics, Inc.
        web link


      Trice Orthopedics
        web link


      TriVentures II Fund
        web link


      V-Wave Ltd.
        web link


      VytronUS, Inc.
        web link


     

    Recent News: